⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
KRYS News
Krystal Biotech, Inc. Common Stock
Palvella Therapeutics Strengthens Leadership Team with Appointment of Rare Disease Commercial Leader Jennifer J. McDonough as Senior Vice President of Market Access and Patient Services
globenewswire.com
PVLA
KRYS
VYJUVEK (Krystal Biotech) Market Research Report 2026: Epidemiology, Pipeline Analysis, Trends, Strategies, and Forecasts, 2020-2025, 2025-2030F, 2035F
globenewswire.com
KRYS
VYJUVEK (Krystal Biotech) Market Research Report 2026: Epidemiology, Pipeline Analysis, Trends, Strategies, and Forecasts, 2020-2025, 2025-2030F, 2035F
globenewswire.com
KRYS
Krystal Biotech to Present at TD Cowen 46th Annual Health Care Conference
globenewswire.com
KRYS
Krystal Biotech Announces Fourth Quarter and Full Year 2025 Financial and Operating Results
globenewswire.com
KRYS
Krystal Biotech to Report Fourth Quarter and Full Year 2025 Financial Results on February 17, 2026
globenewswire.com
KRYS
Krystal Biotech Announces RMAT Designation Granted by FDA to KB707 for the Treatment of Advanced or Metastatic Non-Small Cell Lung Cancer
globenewswire.com
KRYS
Krystal Biotech Provides Business Update at 44th Annual J.P. Morgan Healthcare Conference
globenewswire.com
KRYS
Krystal Biotech Announces Positive Interim Clinical Update from KB407 Phase 1 CORAL-1 Study with Confirmation of Wild-Type CFTR Delivery to the Lungs of Patients with Cystic Fibrosis
globenewswire.com
KRYS
Krystal Biotech to Announce Interim Clinical Update from Highest Dose Cohort of Phase 1 CORAL-1 Study Evaluating KB407 in Patients with Cystic Fibrosis
globenewswire.com
KRYS